Screening over 100 000 patients in 39 general practices in the Netherlands for anticoagulation underprescription in atrial fibrillation: a descriptive, cross-sectional study
Open Access
Abstract
Objectives: To investigate the underprescription of oral anticoagulation (OAC) in individual atrial fibrillation (AF) patients in primary care. Setting: Screening of patient records in 39 participating general practitioners (GPs) across the Netherlands. Participants: We screened 101 207 patient records identifying 2375 non-valvular AF patients. Methods: Using electronic patient files, we were able to screen the entire GP population for AF, CHA 2 DS 2 -VASc stroke risk scores, and the use of guidelines recommended OAC prescription. In case of a deviation from guidelines recommended OAC prescription, we checked the electronic patient file for any documented reason. Additionally, 6 weeks following the screening, we asked all GPs to provide information on any actions taken for the underprescribed patients. Results: We found a mean CHA 2 DS 2 -VASc score of 3.2. OAC prescription consisted of direct OAC in 1342/1984 (68%) and vitamin K-antagonists in the remainder of patients. OAC underprescription was present in 93/944 (9.9%) females and 101/1374 (9.7%) in males, respectively. In 111/146 (76.0%) of the underprescribed AF patients, no reason to withhold OAC was reported. Reported reasons to withhold OAC were patient refusal (n=10), cardiologist advice (n=7) and high risk of bleeding (n=7). Data regarding actions following the identification of OAC underprescription were available for 92/194 (47%) of the OAC underprescribed cases. After consultation OAC was initiated in 9/92 (10%) only. Conclusions: In this large Dutch study among GPs, we observed 9.8% underprescription of OAC in AF patients. In 76% of the AF patients lacking a prescription for OAC, no documentation for deviating from the guidelines was found. Only in a minority of cases detection of OAC underprescription lead to OAC initiation.Keywords
Funding Information
- Bristol-Myers Squibb (n/a (kinase was funded by BMS/pfizer))
This publication has 25 references indexed in Scilit:
- Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for strokeAmerican Heart Journal, 2015
- The ReplyThe American Journal of Medicine, 2014
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Factors Associated with Undertreatment of Atrial Fibrillation in Geriatric Outpatients with Alzheimer DiseaseAmerican Journal of Cardiovascular Drugs, 2013
- Prognosis and Guideline-Adherent Antithrombotic Treatment in Patients With Atrial Fibrillation and Atrial FlutterChest, 2011
- The burden of atrial fibrillation in the NetherlandsNetherlands Heart Journal, 2011
- Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic ReviewThe American Journal of Medicine, 2010
- Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial FibrillationDrugs & Aging, 2010
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Translating the Results of Randomized Trials into Clinical PracticeStroke, 2006